Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia

• Published in: Medicina (Kaunas, Lithuania) Vol. 59; no. 4; p. 758
• Main Authors: Takigawa, Masaki, Tanaka, Hiroyuki, Suwa, Junichi, Obara, Tomoya, Maeda, Yohei, Sato, Mamoru, Shimazaki, Yoshitomo, Onoda, Toshihisa, Ishigami, Akihito, Ishii, Toshihiro
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2023; MDPI
• Subjects: Accuracy; Anti-Bacterial Agents - therapeutic use; Antibiotics; Antimicrobial agents; Blood; Body mass index; Creatinine; Dosage and administration; dosing design; Drug dosages; Drug Monitoring; Drug therapy; Drug utilization; Evaluation; febrile neutropenia; Febrile Neutropenia - drug therapy; hematological malignancy; Humans; Management; Neutropenia; Neutrophils; Nosocomial infections; Patients; Pharmacokinetics; Physiological aspects; Staphylococcus infections; teicoplanin; Teicoplanin - pharmacokinetics; Teicoplanin - therapeutic use; Therapeutic drug monitoring; Japan; United States > US; teicoplanin; pharmacokinetics; febrile neutropenia; hematological malignancy; dosing design; therapeutic drug monitoring

: Teicoplanin (TEIC) is an effective drug for patients with febrile neutropenia (FN); however, it has been reported that these patients may have increased TEIC clearance compared with patients who do not have FN. The purpose of this study was to study therapeutic drug monitoring in patients with FN...